Právní předpis byl sestaven k datu 25.03.2026.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
x xxxxxxxxxx xxxxxxx očkovacích xxxxx pro pravidelná, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx rok 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx rok 2023:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx méně xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx filamentosum (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx hepatitidis X (XXx)2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx antigenu
typus 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 D xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx x polysaccharidum
(Polyribosylribitoli phosphas) 10 mikrogramů
conj. cum xxxxxx. xxxxxxxx jako xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 xxxxxxxxxxx xx hydroxid xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx DNA technologií xx kultuře xxxxxxxxxxxx xxxxx Saccharomyces cerevisiae)
3 xxxxxxxxxxx na fosforečnan xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ b (XXxXXxxXXXXXX)
Xxxxx dávka1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx méně xxx 20 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxx anatoxinum xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 mikrogramů
Virus Poliomyelitidis (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxxx X5 10 mikrogramů
Polyribosylribitoli xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 mikrogramů
(Polyribosylribitoli xxxxxxxx)
xxxxxxxxx cum xxxxxx xxxxxxxxxx 22-36 mikrogramů
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx hlinitý (0,6 xx Al3+)
2 xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx na XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx imunochemickou xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx DNA xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxx polymorpha
NEBO
1ab) Xxxxxxx xxxxx záškrtu, xxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx) x konjugovaná xxxxxxx xxxxx Haemophilus xxxx x (adsorbovaná)
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 IU
Tetani xxxxxxxxxx1 xx xxxx xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx typi 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx antigenu5
Polysaccharidi Xxxxxxxxxx xxxxxxxxxx typus x
(Xxxxxxxxxxxxxxxxxxx phosphas) 3 xxxxxxxxxx xxxxxxxxxx cum xxxxxxxxx xxxxxxxxxxxx xxxxx x2 50 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 mg Xx3+)
2 adsorbováno xx xxxxxxxxxxx xxxxxxxx hlinitý xxxxxx (0,15 xx Xx3+)
3 vyrobeno xxxxxxxxxxxxx XXX xxxxxxxxxxx v xxxxxxxxxxxx buňkách Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx na Xxxx xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx antigenu xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 IU
Pertussis anatoxinum* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69 xX) 8 xxxxxxxxxx
* xxxxxxxxxxx na xxxxxxxx xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx x dávivému xxxxx (xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Tdap)
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 mg xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Očkovací xxxxx proti xxxxxxx, xxxxxx a dávivému xxxxx (xxxxxxxxxx komponenta) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx méně xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 adsorbováno na xxxxxxxxxxx xxxxxxxx hlinitý (Xx(XX)3) 0,3 miligramů Xx3+ x fosforečnan xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
Xxxxx dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací xxxxx xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X x xxxxxx xxxxxxx:
Xxxxx dávka obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx X - 10 mikrogramů
1f) xxxxxxxx látka proti xxxxxx xxxxxxxxxx B x xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) očkovací xxxxx xxxxx spalničkám, xxxxxxxxxx x zarděnkám:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Schwarz) xxx. 103,0 infekční dávka xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx kuřecích xxxxxx
2 xxxxxxxxx na xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
1xx) xxxxxxxx látka proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx morbillorum1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxx Lynn™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx buněčné xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx plicních WI-38 xxxxxxxxxxxxx.
1x) xxxxxxxx xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Xxxxxxx).....40 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx)........32 antigenních X xxxxxxxx*
* nebo xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx imunochemické xxxxxx.
1xx) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx x xxxxxx proteinem XXX197 a xxxxxxxxxx xx fosforečnan hlinitý (0,125 xx xxxxxxx).
1xxx) xxxxxxxxxxxxxxx očkovací xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9X, 10X, 11X, 12F, 14, 15B, 17F, 18X, 19F, 19X, 20, 22F, 23X, 33X.
1x) očkovací látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx méně xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Lf)
Tetani xxxxxxxxxx1 - xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 - 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1)2 - 8 X jednotek xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx xxxxxxxx
1 Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx VERO xxxxxxx
XXXX
1xx) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx 2 XX* (2,5 Xx)
Xxxxxx anatoxinum xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 mikrogramů
Virus poliomyelitidis (xxxxxxxxxxx)**
xxxxx 1 40 X jednotek xxxxxxxx
xxxxx 2 8 X xxxxxxxx antigenu
typus 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx fosforečnan xxxxxxx 1,5 mg (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Evropském xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) očkovací xxxxx xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X pro xxxxx zařazené xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 xx) xxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 adjuvovaný na XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (MPL)2 50 xxxxxxxxxx
2 adsorbovaný xx xxxxxxxxxxx hlinitý (xxxxxx 0,5 miligramu Xx3+)
3 xxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli pro xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 mikrogramů
2b) xxxxxxxx xxxxx proti xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx virové hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx spalničkám, příušnicím x zarděnkám:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx pro xxxxxxxx xxxxxxx503
1 pomnoženo na xxxxxxx kuřecích embryí
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx dávka xxxxxxx kultury
NEBO
2da) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxx Xxxx™, hladina X) xx méně xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx buněčné xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx embryí.
2 xxxxxxxx xx xxxxxxxx diploidních xxxxxxxx XX-38 fibroblastech.
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X inactivatum
3c) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) min. 103,7 xxxxxxxx dávka xxx buněčnou kulturu503
Rubeolae xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx buněčnou xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx embryí
2 pomnoženo xx lidských xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) očkovací látka xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) ne xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Xxxx™, hladina B) xx xxxx xxx 12,5x103 XXXX503
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně xxx 1x1103 XXXX503
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx., MBA, XXXX, x. r.
Informace
Právní xxxxxxx č. 41/2023 Xx. xxxxx xxxxxxxxx dnem 22.2.2023.
Xx xxx xxxxxxxx právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx jednotlivých xxxxxxxx norem xxxxxx xxxxxxxx předpisů v xxxxxxxx xxxx aktualizováno, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.